Latest Breaking News On - டெவன் கிறிஸ்டி - Page 3 : comparemela.com
Numinus Wellness Inc looking to position itself at the forefront of psychedelics for healing and wellness
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Numinus Wellness Inc reports its trial for MDMA-assisted therapy is in pre-implementation stage
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
In other industry news of note:
Mydecine Innovations Group (CSE:MYCO) (MYCO.CNQ), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, recently announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. As part of the agreement, ProPharma Group will provide regulatory advisement as the company seeks approval from the Food and Drug Administration (FDA) for its drug development platform as well as the Company s various stage clinical trials. ProPharma Group is a globally recognized firm with a strong track record of working with life sciences and biopharma companies to ensure full compliance with all FDA regulations, including all necessary steps for eventual global federal approvals, said Josh Bartch, CEO and Co-Founder of Mydecine. Mydecine cur
Palm Beach, FL – December 16, 2020 – Health Canada, in a recent “breakthrough Exemption” has quietly
expanded its list of who can legally possess and consume psilocybin-containing mushrooms by granting 16 health-care professionals the same exemptions it gave more than a dozen patients with terminal and mental illnesses, according to TheraPsil, a Victoria non-profit that has been behind the struggle to treat a list of mental health issues, including debilitating depression, PTSD and even terminal cancer patients. Psilocybin is currently being studied for its potential to treat various conditions such as anxiety, depression, obsessive compulsive disorder and problematic drug use. It is important to note that studies involving the use of Psilocybin require administration of the purified active ingredient in clinically supervised settings. As of right now, there are no approved therapeutic products containing Psilocybin in Canada. Active companies in news today include
Psychedelic Drugs Could Create a $100 Billion Investment Opportunity
With psychedelic drugs showing promise with mental health issues, investors have just begun to push into a space that could be worth up to $100 billion, according to Tania Gonsalves, analyst for Canaccord Genuity Capital Markets, as quoted by Psychedlic Spotlight. She added, “the companies that will emerge as the winners will have deep pockets, patentable products and a well-thought-out reimbursement strategy. Helping, more cities are just beginning to decriminalize psychedelics, like psilocybin. For example, Denver, Oakland, and Santa Cruz have legalized the use of psilocybin. Oregon also became the first state to legalize psilocybin in a therapeutic setting. With excitement growing with psychedelics, some of the top companies to watch include
vimarsana © 2020. All Rights Reserved.